cancer immunotherapy
Coverage of cancer immunotherapy in the Nexus archive.
- Opinion: I’ve spent 40 years in research. I have never seen a threat to science like the new grantmaking rule
The article highlights medical advancements like survivable childhood leukemia and cancer immunotherapy, crediting the American research enterprise. It criticizes a new federal grantmaking rule as a threat to scientific progress.
- SMALL CAP IDEA: Poolbeg Pharma and the oral drug that could unlock cancer immunotherapy's biggest problem
Poolbeg Pharma is developing an oral drug aimed at addressing a major challenge in cancer immunotherapy. The treatment could potentially enhance the effectiveness of existing immunotherapy approaches.
- The Ballad of TIGIT
The article 'The Ballad of TIGIT' discusses the protein TIGIT, a target in cancer immunotherapy research. It links to the original content on owlposting.com and Hacker News comments. The article has minimal engagement with 5 points and 0 comments.
- China's Innovent Biologics signs drug deal with Pfizer worth up to $10.5bn
China's Innovent Biologics has signed a drug deal with Pfizer worth up to $10.5 billion. The agreement involves collaboration on a cancer immunotherapy drug.